Related Experiment Video
Updated: Oct 17, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
A Raf-induced, MEK-independent signaling pathway regulates atrial natriuretic factor gene expression in cardiac
1Huntsman Cancer Institute, Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA.
Abstract:
The atrial natriuretic factor (ANF) gene is activated in cardiac myocytes by Ras and its effector Raf. However, MEK, the best-characterized Raf substrate, cannot efficiently activate ANF suggesting that Raf uses a MEK-independent pathway to activate ANF. By manipulating MEK and Raf activities so that they are equally effective at activating ERK, we now demonstrate that Raf activates at least two signaling pathways in cardiac myocytes that regulate the ANF promoter; the MEK-->ERK pathway inhibits ANF gene expression while a Raf-induced, MEK-independent pathway activates expression. This mechanism may provide increased ability to regulate ANF expression in response to hypertrophic stimuli.
Insights
Ras and Raf signaling pathways in cardiac myocytes differentially regulate the atrial natriuretic factor (ANF) gene. A MEK-ERK pathway inhibits ANF expression, while a MEK-independent pathway activates it.
Area of Science:
- Molecular biology
- Cardiovascular science
- Cell signaling
Background:
- The atrial natriuretic factor (ANF) gene plays a crucial role in cardiovascular homeostasis.
- Ras and its downstream effector Raf are known activators of ANF gene expression in cardiac myocytes.
- The precise mechanisms by which Raf regulates ANF are not fully understood, particularly regarding the role of MEK and ERK signaling.
Purpose of the Study:
- To investigate the distinct signaling pathways initiated by Raf in cardiac myocytes that control ANF gene expression.
- To determine whether Raf utilizes MEK-dependent and/or MEK-independent pathways to modulate ANF promoter activity.
- To elucidate the opposing roles of the MEK-ERK pathway and a novel MEK-independent pathway in ANF regulation.
Main Methods:
- Utilized genetic manipulation to control MEK and Raf activities in cardiac myocytes.
- Assessed the impact of these manipulations on ERK activation.
- Quantified the effects on ANF promoter activity to delineate signaling pathway contributions.
Main Results:
- Raf activates at least two distinct signaling pathways in cardiac myocytes that influence the ANF promoter.
- The MEK-ERK pathway was found to inhibit ANF gene expression.
- A novel Raf-induced, MEK-independent pathway was identified that activates ANF gene expression.
Conclusions:
- Raf employs both MEK-dependent inhibitory and MEK-independent activating pathways to regulate ANF gene expression in cardiac myocytes.
- This dual regulatory mechanism offers a sophisticated system for controlling ANF levels in response to physiological stimuli like cardiac hypertrophy.
- Understanding these pathways provides insights into cardiac function and potential therapeutic targets.
Related Concept Videos
MAPK Signaling Cascades
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
